Sells it, part of Patient And Digital Solutions“Our teams across the country provide staff augmentation services inside transplant centers, helping them operate efficiently.”
Latest 10-KFY2025Mixed ·
Pharmacy and Ottr expansion drive growth beyond testing, while reimbursement and collection adjustments limit revenue per test.
Revenue$379.8MYoY +13.8%
Net income−$21.4Mvs $52.5M year ago
Latest 10-QQ3 FY2026Positive ·
Naveris adds NavDx oncology testing as lab products exit; accelerating transplant demand and older-test revenue recognition fuel growth.
Revenue$139.4MYoY +39.3%
Net income$19.3Mvs $1.7M year ago
Latest 8-KPositiveEarningsGuidance raised ·
Testing Services growth, including NavDx oncology, fuels higher FY2026 revenue guidance of $520M–$530M.
Latest 8-KPositiveDeal completed ·
Sold Lab Products to Eurobio for $171.7M and acquired Naveris for $161.8M upfront, adding NavDx specialty oncology testing.
Latest 8-KExecutive payShareholder vote ·
Stockholders approved adding 1.6M shares to the 2024 Equity Incentive Plan reserve.
Sells it 6%, $4.5B a quarter“Intersegment revenue principally reflects pharmacy and care-services transactions between Evernorth and Cigna Healthcare.”
Latest 10-QQ3 FY2026MixedRestructuring ·
Rebate-free investment and contract renewals squeeze Evernorth’s pharmacy-benefit earnings; specialty care provides an offset.
Revenue$73.7BYoY +5.6%
Net income$1.4BYoY −22.8%
Latest 8-KEarningsGuidance raised ·
Pharmacy Benefit Services renewals and investments squeezed income; FY2026 adjusted EPS outlook raised to at least $30.60
Latest 8-KLeadership change ·
Donna F. Zarcone will retire from Cigna’s board effective Dec. 31, 2026.
Sells it“CVS reported about 9,000 retail locations, more than 1,000 walk-in and primary-care clinics, approximately 87 million PBM plan members and an estimated 37 million people served through health insurance products.”
Latest 10-QQ3 FY2026Mixed ·
Planned split separates Aetna and Caremark from CVS Pharmacy as insurance profitability improves and pharmacy pricing pressure persists.
Sells it“The company describes Carelon’s strategy as integrating physical, behavioral and social services, applying data and provider enablement, and expanding value-based care, including home and virtual care for complex populations.”
Latest 10-QQ3 FY2026Mixed ·
Carelon’s specialty pharmacy and care-services gains fell short of offsetting medical-cost pressure in Health Benefits.
Revenue$51.4BYoY +1.4%
Net income$1.4BYoY +14.8%
Latest 8-KGuidance reaffirmed ·
FY2026 outlook reaffirmed for investor meetings: EPS of at least $22.00 diluted and $29.00 adjusted.
Latest 8-KPositiveEarningsGuidance raised ·
Carelon growth contrasts with Health Benefits weakness; FY2026 adjusted EPS outlook raised to ≥$29
Sells it 96%, $19.0B a quarter“HCA operated 182 U.S. hospitals across its geographic groups and seven hospitals in England, along with 117 freestanding surgery centers and 30 freestanding endoscopy centers.”
Latest 10-QQ3 FY2026Negative ·
Expired enhanced Exchange tax credits and fewer Medicaid conversions swelled uninsured admissions, raising uncompensated-care costs as patient volumes grew.
Revenue$19.8BYoY +3.6%
Net income$1.6BYoY −3.9%
Latest 8-KDebt financing ·
Completed a $6.5B senior notes offering through HCA Inc., backed by HCA Healthcare’s senior unsecured guarantee.
Latest 8-KPositiveEarningsGuidance raised ·
Exchange coverage losses drove a ≈$400M pretax headwind; better admission growth and costs support an upper-half FY2026 outlook.
Sells it 8%, $8.6B a quarter“A strategic review begun in Q4 2025 focused on advancing and scaling core operations, including Optum Health’s value-based-care business.”
Latest 10-QQ3 FY2026MixedRestructuring ·
Pricing and market exits shrink UnitedHealthcare membership; reserve releases and divestitures bolster Optum Health’s earnings.
Revenue$112.7BYoY −0.4%
Net income$4.1BYoY +75.0%
Latest 8-KLeadership change ·
Former Children’s Hospital of Philadelphia CEO Madeline Bell joins the board, bringing patient-care and hospital leadership experience.
Latest 8-KPositiveEarningsGuidance raised ·
UnitedHealthcare pricing and benefit changes lift earnings; FY2026 adjusted EPS outlook raised to at least $20.50
Latest 8-KInvestor update ·
Leaders will discuss strategy, recent results and end-market expectations at the Wells Fargo Healthcare Conference.
Sells it“Veriheal Inc. (“Veriheal”) was founded in the state of Delaware on November 17, 2017, by Joshua Green and Samuel Adetunji to provide concierge services to patients seeking prescription cards for medical marijuana.”
Latest S-1/Aamended IPO prospectusNegativeBankruptcy / going concernAccounting issueControlled company ·
Connects patients with physicians for medical-cannabis certifications; FY2025 revenue fell 34.9% Y/Y as state restrictions hit consultations
Sells it, part of Walmart US, Walmart International, Sam's Club US“Health and wellness includes pharmacy, over-the-counter drugs and other medical products, and optical services.”
Latest 10-KFY2026PositiveCEO/CFO change ·
Store-fulfilled eCommerce drove U.S. comparable sales, while International delivery spending and a PhonePe charge held back operating profit.
Revenue$713.2BYoY +4.7%
Net income$21.9BYoY +12.6%
Latest 10-QQ2 FY2027Legal / investigation ·
Tariff refunds exceeded the operating-profit increase; store- and club-fulfilled delivery drove most eCommerce growth.
Revenue$187.9BYoY +5.9%
Net income$6.4BYoY −9.4%
Latest 8-KPositiveEarningsGuidance raised ·
Better Walmart U.S. merchandise mix and higher membership income lift profit; FY2027 adjusted EPS outlook raised to $2.84–$2.89
Latest 8-KLeadership change ·
Caterpillar chairman and CEO Joseph E. Creed joins Walmart’s board and its Audit and Strategic Planning and Finance committees.
Latest 8-KDebt financing ·
Eight-tranche U.S. and Canadian senior debt offering to raise $2.99B and C$4.98B net before transaction expenses.
Latest 8-KGovernance changeShareholder vote ·
Shareholders approved a charter amendment allowing Walmart to limit certain officers’ liability under Delaware law.
No companies have a recent 8-K matching these events.